Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 163, Issue , 2016, Pages 77-87

  Claro da Silva, Tatiana ^a   Hiller, Christian ^a   Gai, Zhibo ^a   Kullak Ublick, Gerd A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Iron; Manganese; SLC30A10; VDRE; Vitamin D; Zinc

Indexed keywords

CARRIER PROTEIN; CERULOPLASMIN; COLECALCIFEROL; HAPTOGLOBIN; IRON; MANGANESE; NEUROPEPTIDE; RETINOID X RECEPTOR; SLC30A10 TRANSPORTER; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; ZINC; CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM CHANNEL; CATION TRANSPORT PROTEIN; HP PROTEIN, HUMAN; LUCIFERASE; PROTEIN BINDING; SLC30A8 PROTEIN, HUMAN; TRPV6 PROTEIN, HUMAN; VANILLOID RECEPTOR; VDR PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ARTICLE; CACO 2 CELL LINE; CELL ADHESION; COMPUTER MODEL; CONTROLLED STUDY; DUODENUM BIOPSY; FLUORESCENCE ANALYSIS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LUCIFERASE ASSAY; MINERAL METABOLISM; MORPHOGENESIS; NEXT GENERATION SEQUENCING; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSPORT KINETICS; VITAMIN D RESPONSIVE ELEMENT; WESTERN BLOTTING; ADULT; AGONISTS; BINDING SITE; CACO-2 CELL LINE; DRUG EFFECTS; DUODENUM; FEMALE; GENE ONTOLOGY; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; PROSPECTIVE STUDY; REPORTER GENE; TRANSCRIPTION INITIATION;

ADULT; BINDING SITES; CACO-2 CELLS; CALCITRIOL; CALCIUM CHANNELS; CATION TRANSPORT PROTEINS; CERULOPLASMIN; DUODENUM; FEMALE; GENE ONTOLOGY; GENES, REPORTER; HAPTOGLOBINS; HUMANS; IRON; LUCIFERASES; MALE; MANGANESE; MOLECULAR SEQUENCE ANNOTATION; PROSPECTIVE STUDIES; PROTEIN BINDING; RECEPTORS, CALCITRIOL; RETINOID X RECEPTORS; TRANSCRIPTIONAL ACTIVATION; TRPV CATION CHANNELS; ZINC;

EID: 84964678918     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2016.04.006     Document Type: Article

References (61)

1. [1] Norman, A.W., From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 88:2 (2008), 491S–499S.
2. [2] Dobnig, H., A review of the health consequences of the vitamin D deficiency pandemic. J. Neurol. Sci. 311:1–2 (2011), 15–18.
3. [3] Holick, M.F., Vitamin D deficiency. N. Engl. J. Med. 357:3 (2007), 266–281.
4. [4] Meyer, M.B., et al. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol. 20:6 (2006), 1447–1461.
5. [5] Jones, G., Prosser, D.E., Kaufmann, M., 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch. Biochem. Biophys. 523:1 (2012), 9–18.
6. [6] Eloranta, J.J., et al. The SLCO1A2 gene: encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor. Mol. Pharmacol. 82:1 (2012), 37–46.
7. [7] Bosomworth, H.J., et al. Efflux function: tissue-specific expression and intracellular trafficking of the Zn transporter ZnT10 indicate roles in adult Zn homeostasis. Metallomics 4:8 (2012), 771–779.
8. [8] Leyva-Illades, D., et al. SLC30A10 is a cell surface-localized manganese efflux transporter: and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. J. Neurosci. 34:42 (2014), 14079–14095.
9. [9] Quadri, M., et al. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia: polycythemia, and chronic liver disease. Am. J. Hum. Genet. 90:3 (2012), 467–477.
10. [10] Girgis, C.M., et al. Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 155:2 (2014), 347–357.
11. [11] Fraga, C.G., Relevance, essentiality and toxicity of trace elements in human health. Mol. Aspects Med. 26:4–5 (2005), 235–244.
12. [12] Zofkova, I., Nemcikova, P., Matucha, P., Trace elements and bone health. Clin. Chem. Lab. Med. 51:8 (2013), 1555–1561.
13. [13] Wang, Y., Zhu, J., DeLuca, H.F., Where is the vitamin D receptor?. Arch. Biochem. Biophys. 523:1 (2012), 123–133.
14. [14] Messeguer, X., et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18:2 (2002), 333–334.
15. [15] Farre, D., et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 31:13 (2003), 3651–3653.
16. [16] Cartharius, K., et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:13 (2005), 2933–2942.
17. [17] Quandt, K., et al. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:23 (1995), 4878–4884.
18. [18] Toell, A., Polly, P., Carlberg, C., All natural DR3-type vitamin D response elements show a similar functionality in vitro. Biochem. J. 352:Pt. 2 (2000), 301–309.
19. [19] Finke, D., Eloranta, M.L., Ronnblom, L., Endogenous type I interferon inducers in autoimmune diseases. Autoimmunity 42:4 (2009), 349–352.
20. [20] Kumar, R., et al. Systematic characterisation of the rat and human CYP24A1 promoter. Mol. Cell. Endocrinol. 325:1–2 (2010), 46–53.
21. [21] Wang, Z., et al. Interplay between vitamin D and the drug metabolizing enzyme CYP3A4. J. Steroid Biochem. Mol. Biol. 136 (2013), 54–58.
22. [22] Pike, J.W., et al. Molecular actions of 1,25-dihydroxyvitamin D3 on genes involved in calcium homeostasis. J. Bone Miner. Res. 22:Suppl. 2 (2007), V16–V19.
23. [23] Rondini, E.A., et al. Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells. Drug Metab. Dispos. 42:3 (2014), 361–368.
24. [24] Eloranta, J.J., et al. Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter. Mol. Pharmacol. 76:5 (2009), 1062–1071.
25. [25] Chun, R.F., et al. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front. Physiol., 5, 2014, 151.
26. [26] Yin, K., Agrawal, D.K., Vitamin D and inflammatory diseases. J. Inflamm. Res. 7 (2014), 69–87.
27. [27] Girgis, C.M., Baldock, P.A., Downes, M., Vitamin D, muscle and bone: integrating effects in development, aging and injury. Mol. Cell. Endocrinol. 410 (2015), 3–10.
28. [28] Le Blanc, S., Garrick, M.D., Arredondo, M., Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism. Am. J. Physiol. Cell Physiol. 302:12 (2016), C1780–5.
29. [29] Campbell, H.D., et al. Human and mouse homologues of the Drosophila melanogaster tweety (tty) gene: a novel gene family encoding predicted transmembrane proteins. Genomics 68:1 (2000), 89–92.
30. [30] Peters, J.L., et al. Targeting of the mouse Slc39a2 (Zip2) gene reveals highly cell-specific patterns of expression: and unique functions in zinc, iron, and calcium homeostasis. Genesis 45:6 (2007), 339–352.
31. [31] Eide, D.J., The SLC39 family of metal ion transporters. Pflugers Arch. 447:5 (2004), 796–800.
32. [32] Wilmsdorff, M.V., et al. Gene expression of glutamate transporters SLC1A1: SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment. World J. Biol. Psychiatry 14:7 (2013), 490–499.
33. [33] Vinh Quoc Luong, K., Thi Hoang Nguyen, L., Vitamin D and Parkinson's disease. J. Neurosci. Res. 90:12 (2012), 2227–2236.
34. [34] Plaitakis, A., Shashidharan, P., Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol. 247:Suppl. 2 (2000), II25–II35.
35. [35] Zhou, Y., Danbolt, N.C., GABA and glutamate transporters in brain. Front. Endocrinol. (Lausanne), 4, 2013, 165.
36. [36] Huang, L., Tepaamorndech, S., The SLC30 family of zinc transporters – a review of current understanding of their biological and pathophysiological roles. Mol. Aspects Med. 34:2–3 (2013), 548–560.
37. [37] Sreedharan, S., et al. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters. Gene 478:1–2 (2011), 11–18.
38. [38] Jeong, J., Eide, D.J., The SLC39 family of zinc transporters. Mol. Aspects Med. 34:2–3 (2013), 612–619.
39. [39] Hoenderop, J.G., Bindels, R.J., Calciotropic and magnesiotropic TRP channels. Physiology (Bethesda) 23 (2008), 32–40.
40. [40] Tuschl, K., et al. Syndrome of hepatic cirrhosis: dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am. J. Hum. Genet. 90:3 (2012), 457–466.
41. [41] Holick, M.F., Chen, T.C., Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87:4 (2008), 1080S–1086S.
42. [42] Dusso, A.S., Puche, R.C., The effect of 1 alpha, 25-dihydroxycholecalciferol on iron metabolism. Blut 51:2 (1985), 103–108.
43. [43] Katsumata, S., et al. Severe iron deficiency decreases both bone formation and bone resorption in rats. J. Nutr. 139:2 (2009), 238–243.
44. [44] Toxqui, L., et al. Effects of an iron or iron and vitamin D-fortified flavored skim milk on iron metabolism: a randomized controlled double-blind trial in iron-deficient women. J. Am. Coll. Nutr. 32:5 (2016), 312–320.
45. [45] Lee, J.A., et al. Low vitamin D levels are associated with both iron deficiency and anemia in children and adolescents. Pediatr. Hematol. Oncol. 32:2 (2016), 99–108.
46. [46] Toxqui, L., Vaquero, M.P., Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis. Nutrients 7:4 (2016), 2324–2344.
47. [47] Ackland, M.L., Michalczyk, A., Zinc deficiency and its inherited disorders – a review. Genes Nutr. 1:1 (2006), 41–49.
48. [48] Nriagu, J., Zinc Toxicity in Humans. 2007, Elsevier B.V.: Elsevier Science extranet, 7.
49. [49] Coneyworth, L.J., et al. Identification of the human zinc transcriptional regulatory element (ZTRE): a palindromic protein-binding DNA sequence responsible for zinc-induced transcriptional repression. J. Biol. Chem. 287:43 (2012), 36567–36581.
50. [50] Yamaguchi, M., Role of nutritional zinc in the prevention of osteoporosis. Mol. Cell. Biochem. 338:1–2 (2010), 241–254.
51. [51] Landete-Castillejos, T., et al. Alternative hypothesis for the origin of osteoporosis: the role of Mn. Front. Biosci. (Elite Ed.) 4 (2012), 1385–1390.
52. [52] Santucci, N.R., et al. Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 59:4 (2014), 455–457.
53. [53] Oxentenko, A.S., Murray, J.A., Celiac disease: ten things that every gastroenterologist should know. Clin. Gastroenterol. Hepatol. 13:8 (2015), 1387–1552.
54. [54] Meyer, R., et al. Dietary elimination of children with food protein induced gastrointestinal allergy – micronutrient adequacy with and without a hypoallergenic formula?. Clin. Transl. Allergy, 4(1), 2014, p31.
55. [55] Allan, K., Devereux, G., Diet and asthma: nutrition implications from prevention to treatment. J. Am. Diet. Assoc. 111:2 (2011), 258–268.
56. [56] Uysalol, M., et al. Serum level of vitamin D and trace elements in children with recurrent wheezing: a cross-sectional study. BMC Pediatr., 14, 2014, 270.
57. [57] Roth, J.A., Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese. Neurotoxicology 44 (2014), 314–325.
58. [58] Stamelou, M., et al. Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. Mov. Disord. 27:10 (2012), 1317–1322.
59. [59] Evatt, M.L., et al. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch. Neurol. 65:10 (2008), 1348–1352.
60. [60] vinh quôc Luong, K., Thi Hoàng Nguyên, L., Vitamin D and parkinson's disease. J. Neurosci. Res. 90:12 (2012), 2227–2236.
61. [61] Suzuki, M., et al. 25-Hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. Mov. Disord. 27:2 (2012), 264–271.